Actively Recruiting
Study Evaluating Danicamtiv Versus Placebo in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Led by Kardigan, Inc. · Updated on 2026-11-04
332
Participants Needed
79
Research Sites
17 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the investigational drug danicamtiv in people with symptomatic genetic and familial dilated cardiomyopathy DCM. This condition causes the heart muscle to weaken and enlarge, reducing its ability to pump blood effectively. There are currently no approved treatments specifically for genetic or familial DCM, so this study aims to assess the safety and effectiveness of danicamtiv compared to a placebo. The study is conducted by Kardigan, Inc. and focuses on improving heart function and exercise capacity over time. Participants will receive either danicamtiv or a placebo twice daily for about 26 weeks. The study is randomized and double-blind, meaning neither participants nor researchers know who receives the drug or placebo. Throughout the study, participants will visit the clinic approximately 12 times for evaluations, tests, and follow-up. These visits will include echocardiograms to assess heart function and exercise tests to measure physical capacity. During the trial, participants will undergo various assessments such as cardiac imaging, exercise capacity tests, and questionnaires about heart-related symptoms. Researchers will monitor changes in heart function measures like left atrial function index and peak oxygen uptake over 26 weeks. Safety and tolerability of the drug will also be closely observed. The total participation duration is about six months, with regular clinic visits to track progress and collect data.
CONDITIONS
Brief Title
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Research Team
K
Kardigan Clinical Trial Information Team
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here